Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Total Assets Over TimeExpanding
Percentile Rank100
3Y CAGR+18.4%
5Y CAGR+16.9%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
+18.4%/yr
vs +9.3%/yr prior
5Y CAGR
+16.9%/yr
Consistent
Acceleration
+9.1pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.2x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$763.63M+31.5%
2024$580.55M+10.3%
2023$526.32M+14.5%
2022$459.67M+97.5%
2021$232.80M-33.4%
2020$349.46M+37.3%
2019$254.53M-20.9%
2018$321.96M+577.9%
2017$47.49M-15.9%
2016$56.47M-